Skip to main navigation
  • IR Home
  • News
  • Events & Presentations
  • Governance
    • Our Team
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financials
    • SEC Filings
  • Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

News Releases

Mar 01, 2023
Rallybio to Present at Upcoming Investor Conferences in March
Feb 27, 2023
EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
Jan 31, 2023
Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
Jan 05, 2023
Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2023

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
Displaying 21 - 24 of 24

Investor Tools

Unimagined therapies. Undreamed outcomes.

Rallybio Newsroom
Linkedin Twitter

info@rallybio.com

234 Church Street
Suite 1020
New Haven, CT 06510

+1 203-859-3820
+1 475-47-RALLY (72559)

© 2023 Rallybio | Terms of Use | Privacy Policy | Community Guidelines